FDA Approves Xadago (safinamide) as an Add-On Treatment for Patients with Parkinson ’s Disease

March 21, 2017 -- The U.S. Food and Drug Administration today approved Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson ’s disease who are currently taking levodopa/carbidopa and experiencing “off” episodes. An...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news